Zealand Pharma A/S | ZEAL - Loan Capital


Zealand Pharma A/S reported 383.14M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Akebia Therapeutics USD 36.39M 11.85M Mar/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Ionis Pharmaceuticals USD 1.91B 6.62M Jun/2026
IQVIA Holdings USD 13.7B 284M Jun/2026
Moderna USD 597M 6M Jun/2026
Organon & Co USD 8.55B 75M Mar/2026
Revvity USD 2.63B 836K Mar/2026
Tectonic Therapeutic USD 17K 26K Mar/2026
Tilray USD 268.59M 3.82M Sep/2025
Viatris USD 12.41B 67.1M Mar/2026
Xeris Pharmaceuticals USD 221.22M 889K Mar/2026
Zealand Pharma A/S 383.14M 727K Dec/2025